4,348 Shares in CVS Health Corporation (NYSE:CVS) Purchased by Petra Financial Advisors Inc.

Petra Financial Advisors Inc. purchased a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,348 shares of the pharmacy operator's stock, valued at approximately $295,000.

Several other large investors have also recently added to or reduced their stakes in the company. Whitebox Advisors LLC purchased a new position in CVS Health in the fourth quarter valued at about $249,000. B&D White Capital Company LLC purchased a new position in CVS Health in the fourth quarter valued at about $417,000. Fairfax Financial Holdings Ltd. Can purchased a new position in CVS Health in the fourth quarter valued at about $121,742,000. Lazard Asset Management LLC increased its holdings in CVS Health by 7.3% in the fourth quarter. Lazard Asset Management LLC now owns 4,290,953 shares of the pharmacy operator's stock valued at $192,617,000 after buying an additional 293,406 shares in the last quarter. Finally, Seizert Capital Partners LLC increased its holdings in CVS Health by 22.8% in the fourth quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock valued at $25,566,000 after buying an additional 105,708 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Down 0.2%

Shares of NYSE CVS opened at $66.69 on Friday. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $72.51. The firm's 50 day moving average price is $64.92 and its 200 day moving average price is $60.40. The firm has a market cap of $84.36 billion, a P/E ratio of 15.92, a price-to-earnings-growth ratio of 0.96 and a beta of 0.56. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The firm had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same quarter last year, the business earned $1.31 earnings per share. CVS Health's revenue was up 7.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

Analysts Set New Price Targets

CVS has been the subject of a number of research analyst reports. Barclays set a $79.00 target price on shares of CVS Health and gave the company an "overweight" rating in a report on Monday, June 2nd. Royal Bank Of Canada increased their target price on shares of CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a report on Monday, May 5th. UBS Group increased their target price on shares of CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Finally, Piper Sandler increased their price target on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research report on Friday, March 21st. Two investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $74.75.

Insiders Place Their Bets

In related news, Director Guy P. Sansone purchased 1,570 shares of the business's stock in a transaction on Thursday, June 5th. The shares were bought at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director now directly owns 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. 1.22% of the stock is currently owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.